Stocks Clock Fourth...
Health Care: Drugs
OxiGene Inc. (OXGN: NASDAQ)
$3.30 0.07 | 2.06%
05/17/13 - 03:39 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| OXGN | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -21.98 | 236.38 | -83.35 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | -0.97 | 0.00 |
Earnings for OXGN:
| EBITDA | -8.00 |
| REVENUE | 156.00K |
Average Earnings Estimates
| Qtr (12/11) | Qtr (03/12) | FY (12/11) | FY (12/12) | |
|---|---|---|---|---|
| Average Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Number of Analysts | 0 | 0 | 0 | 0 |
| High Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Low Estimate | $n.a. | $n.a. | $n.a. | $n.a. |
| Prior Year | $-5.66 | $-0.13 | $-5.96 | $n.a. |
| Growth Rate (Year over Year) | n.a.% | n.a.% | n.a.% | n.a.% |
Portfolios with OXGN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorSmall-Cap Stocks in Danger ...
- UserMy Portfolio
- UserMy Portfolio
- Contributor5 Drug Stock Losers of 2010
- UserASCO 2010 Part 2
- UserBIN
- UserJBOND Portfolio 1
- UserASCO 2009 Nymph's Watch List.
Latest OXGN Headlines from TheStreet
- OXiGENE Reports First Quarter 2013 Financial Results 05.06.13 | 04:05 pm
- OXiGENE Announces Completion Of Enrollment Of ZYBRESTAT(R) Phase 2 Ovarian Cancer Trial 04.24.13 | 04:04 pm
- OXiGENE Announces First Quarter 2013 Earnings Conference Call And Webcast 04.24.13 | 06:04 am
- OXiGENE Announces $5 Million Private Placement 04.11.13 | 08:04 am
- OXiGENE Announces Issuance Of Patent For Benzosuberenes, A Novel Anticancer Class Of Agents 03.20.13 | 04:03 pm
- OXiGENE Reports Full Year 2012 Financial Results 03.12.13 | 04:03 pm
- OXiGENE Announces Year-End 2012 Earnings Conference Call And Webcast 03.04.13 | 02:03 pm
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- OXiGENE Announces ZYBRESTAT(R) Plus Avastin(R) Continues To Be Well Tolerated In Second Interim Toxicity Analysis Of A Phase 2 Ovarian Cancer Trial 02.06.13 | 04:02 pm
- 3 Stocks Under $5 Making Big Moves 02.05.13 | 02:02 pm
Press Releases for OXGN
Partner Headlines for OXGN
- OXiGENE Announces Changes to Board of Directors - Benzinga 09.09.11 | 04:09 pm
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- ZYBRESTAT Results Suggest Improvement in Overall Survival in Phase 2/3 Study in Anaplastic Thyroid Cancer - Benzinga 06.06.11 | 04:06 pm
- Morning Market Movers - Benzinga 06.06.11 | 09:06 am
- 7 Big Movers That Investors Must Watch This Week - Seeking Alpha 06.06.11 | 08:06 am
- ASCO 2011: Opportunities for Biotech Investor Success and Failure - Seeking Alpha 05.02.11 | 09:05 am
- UPDATE 1-Oxigene reports positive data on cancer drug - Reuters 10.11.10 | 08:10 am
- Three Promising Small-Cap Cancer Plays - Seeking Alpha 05.17.10 | 08:05 am
- UPDATE 1-Oxigene says auditors raise going concern doubts - Reuters 03.19.10 | 08:03 am
- UPDATE 1-Oxigene to cut half the jobs, sees Q1 charge - Reuters 02.11.10 | 11:02 am
